Silence Therapeutics reported $13.61M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AstraZeneca USD 31.55B 1.02B Jun/2026
Autolus Therapeutics Ltd USD 68.79M 5.19M Jun/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Novartis USD 31.75B 374M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Silence Therapeutics USD 13.61M 3.77M Dec/2025